https://github.com/metapsy-project/data-depression-psiloctr

Database of psilocybin-assisted therapies for adults with depression versus control conditions.
https://github.com/metapsy-project/data-depression-psiloctr

data

Last synced: 4 months ago
JSON representation

Database of psilocybin-assisted therapies for adults with depression versus control conditions.

• Host: GitHub
• URL: https://github.com/metapsy-project/data-depression-psiloctr
• Owner: metapsy-project
• License: other
• Created: 2025-05-15T16:08:53.000Z (about 1 year ago)
• Default Branch: master
• Last Pushed: 2025-11-18T20:52:45.000Z (7 months ago)
• Last Synced: 2025-11-18T22:16:16.253Z (7 months ago)
• Topics: data
• Homepage: https://sypres.io
• Size: 193 KB
• Stars: 0
• Watchers: 0
• Forks: 0
• Open Issues: 0
• Metadata Files:
  • Readme: readme.md
  • License: license

Awesome Lists containing this project

README

          
## **The `data-depression-psiloctr` dataset** 📊 

[](https://doi.org/10.5281/zenodo.15714852) 

The `data-depression-psiloctr` dataset is a meta-analytic research domain ([MARD](https://docs.metapsy.org/uploads/ebmental-2022-300509.pdf)) 

on psilocybin-assisted therapies for adults with depressive symptoms. 

This MARD is part of the  [Metapsy project](https://www.metapsy.org/). 

The date of the last search update is provided [here](https://github.com/metapsy-project/data-depression-psiloctr/blob/master/metadata/last_search.txt). 

This dataset includes **psilocybin therapies vs. control ('psilo vs ctr')** comparisons. Effect sizes are provided for outcomes at post-test and long-term follow-ups, if available. 

This living database has been developed by the [**Sypres**](https://sypres.io/) (Synthesis of Psychedelic Research Studies) Collaboration. Further information on Sypres and its underlying methodology can be found in this  [published article](https://sypres.io/assets/pdfs/natmh2025.pdf).

The dataset follows the [Metapsy data standard](https://docs.metapsy.org/data-preparation/format/). All included information has been independently extracted two researchers. Risk of bias ratings were conducted using the Cochrane Collaboration Risk of Bias Tool (Version 2).